InVirtuoLabs

A Swiss drug discovery startup pairing generative AI with physics-based molecular simulation to design and optimize small-molecule therapeutics.

Location: Lugano, Switzerland

1 model

Models (1)

InVirtuoLabs / Max Planck Institute of Biochemistry

Released September 30, 2025

———

Discrete flow generative model over fragmented SMILES for de novo, fragment-constrained, and property-optimized small-molecule drug design.

Small molecule